← Open Payments lookup

PAUL HWANGBO: Open Payments

NPI 1063024404 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,302 in 95 payments from 22 companies in 2025. Trend: 2023 $1,993 · 2024 $2,007 · 2025 $2,302

Food & beverage: $2,202Education: $100
CompanyPaymentsAmount
GlaxoSmithKline, LLC.16$392
AstraZeneca Pharmaceuticals LP16$355
Verona Pharma, Inc.9$259
Viatris Specialty LLC5$143
Grifols USA, LLC5$111
Regeneron Healthcare Solutions, Inc.3$101
SANOFI-AVENTIS U.S. LLC1$100
Electromed, Inc.9$99
Baxter Healthcare4$95
Takeda Pharmaceuticals U.S.A., Inc.3$72

Products named: NUCALA, DUPIXENT, Ohtuvayre, TEZSPIRE, YUPELRI, Prolastin-C Liquid, TRELEGY ELLIPTA, FASENRA.

Industry payments across GA — which companies pay providers there.